Podcast

Giving Shingles Immunization Your Best Shot: Implementing a Shingles Vaccination Protocol in Your Practice

Launch Date
08/26/2020
Credit Amount
0.00 Expired
Credit Expires
12/31/2021

Faculty

William Schaffner, MD
Professor of Preventive Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN
William Schaffner, MD

Dr. William Schaffner is Professor of Preventive Medicine in the Department of Health Policy and Professor of Infectious Diseases at the Vanderbilt University School of Medicine, Nashville, Tennessee.

Dr. Schaffner’s primary focus has been the prevention of infectious diseases. He is a strong proponent of collaboration between academic medical centers and public health institutions. He has worked extensively on the effective use of vaccines and has been a member of expert advisory committees that establish national vaccine policy.

Dr. Schaffner is committed to the communication of disease prevention with the general public and regards this as a teaching opportunity. He is often invited to comment on communicable disease issues on local and national media, translating research and public health events into language that the public can understand.

After graduating from Yale in 1957, Schaffner attended the University of Freiburg, Germany as a Fulbright Scholar. He graduated from Cornell University Medical College in 1962 and completed residency training and a Fellowship in Infectious Diseases at Vanderbilt. He was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC) for two years. He returned to Vanderbilt after that tour of duty and established a long collaboration with the Tennessee Department of Health and the CDC.

Anthony Cunningham, MD, MBBS
Professor of Medicine and Health, University of Sydney Medical School
Director, Westmead Institute for Virus Research
Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2)
New South Wales / Australian Capital Territory State Branch Chair, Australian Academy of Health and Medical Sciences, Westmead, NSW
Anthony Cunningham, MD, MBBS

Professor Anthony (Tony) Cunningham, AO, MD, MBBS stepped down as Executive Director of The Westmead Institute for Medical Research after 23 years (1996 – 2019) and now continues as Director of the Institute’s Centre for Virus Research and Professor, Faculty of Medicine and Health in the University of Sydney. He is also Director of the Australian Centre for HIV and Hepatitis Virology Research (ACH2), which is funded directly by the Australian Government, as well as the NSW/ACT State Branch Chair, The Australian Academy of Health and Medical Sciences.

He is a clinician scientist who trained in infectious diseases and virology research at the University of Melbourne and as a postdoctoral fellow in infectious diseases at Stanford University. His longstanding research is in herpes virus and HIV immunology relevant to vaccine development, culminating in lead international roles in the pivotal trials of a vaccine candidate for herpes simplex and a highly efficacious vaccine for Herpes zoster. He has published extensively in most aspects of immunization for herpes zoster and more broadly on immunization in general. He is currently investigating the mechanism of action of adjuvants to counteract declining immunity and vaccine efficacy in the ageing.

Iris Gorfinkel, MD, CM
Founder and Principal Investigator, PrimeHealth Clinical Research, Toronto, ON
Iris Gorfinkel, MD, CM

Iris Gorfinkel, MD, CM, is a family physician and Founder/Principal Investigator of PrimeHealth Clinical Research. She has participated in over 60 clinical trials and has a special interest in vaccination research. She helped co-author seminal papers on Shingrix and sat as a co-chair on the Shingrix Advisory Board. Additionally, Dr. Gorfinkel is active in-patient advocacy and produces a regular medical radio column on CBC Radio One.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Shingles, or herpes zoster, is a common secondary infection for older patients. Almost all individuals over the age of 50 are latently infected with varicella zoster virus (VZV) and therefore are at risk of developing shingles with reactivation of latent VZV. Individuals who develop shingles often experience debilitating postherpetic neuralgia (PHN), secondary skin infections, eye problems, or neurologic conditions including an increased risk of stroke.

Despite the existence of vaccines, the number of people vaccinated for shingles remains low. In large part, this is due to the majority of individuals being unaware that a vaccine exists, as clinicians often fail to initiate discussion about it.

This CME Outfitters Live and OnDemand webcast will focus on the burden imposed by shingles, improving uptake of vaccination and series completion for shingles through patient education, and applying real-world strategies to implement shingles immunization protocols.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Identify the primary risk factors and clinical and quality of life (QoL) complications imposed by shingles.
  • More frequently and effectively educate eligible patients about shingles vaccination to improve uptake of vaccination and series completion for shingles.
  • Apply real-world strategies to implement shingles immunization that consider safety and efficacy of available therapies, storage and administration, and pharmacy-based vaccination.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Identify the primary risk factors and clinical and QoL complications imposed by shingles.
  • Explain ways to educate eligible patients about shingles vaccination to improve uptake of vaccination and series completion for shingles.
  • Summarize real-world strategies to implement shingles immunization that consider safety and efficacy of available therapies, storage and administration, and pharmacy-based vaccination.

Financial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-110-H01-P

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schaffner has no disclosures to report.

Dr. Cunningham reports he is on the advisory committee for GlaxoSmithKline.

Dr. Gorfinkel reports she receives research support from GlaxoSmithKline and Merck & Co., Inc. She is on the advisory committee and consultant for GlaxoSmithKline.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Kashemi D. Rorie, PhD (planning committee)
  • Jeffrey Helfand, DO (peer reviewer)
  • Mae Ochoa, RPh (peer reviewer)
  • Evan Luberger (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-110-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

TV-115-082620-06

Giving Shingles Immunization Your Best Shot: Implementing a Shingles Vaccination Protocol in Your Practice
Event Date: 08/26/2020